Laurent Fischer
CIK 1379344 · CEO, PRESIDENT AND DIRECTOR · last filed 2026-06-08
Laurent Fischer is a CEO, PRESIDENT AND DIRECTOR who has filed 48 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ATAI, was dated Jun 8, 2026. Across all open-market trades the lifetime net is +$899.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.07M
6
48
$899.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATAI | Director | — | $3.92 | — | $0 | 3 | 2026-06-08 |
| MIRM | Director | 10,727 | $99.34 | $1.07M | $69.0K | 9 | 2026-06-02 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | CEO, PRESIDENT AND DIRECTOR | 522,666 | $4.36 | $2.28M | $830.9K | 21 | 2025-12-10 |
| CTI BIOPHARMA CORP (CTIC) Delisted | Director | — | $9.09 | — | $0 | 8 | 2023-06-26 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Chief Executive Officer | — | — | — | $0 | 3 | 2016-01-14 |
| PANACOS PHARMACEUTICALS, INC. (PANC) Delisted | Director | — | — | — | $0 | 3 | 2008-06-30 |
Recent Filings
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | ATAI | Grant (A) | — | $0 | EDGAR |
| 2026-06-02 | MIRM | Exer (M) | +3,977 | $0 | EDGAR |
| 2025-12-10 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Mixed | −249,179 | $630.0K | EDGAR |
| 2025-12-08 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +128,699 | $553.9K | EDGAR |
| 2025-06-27 | ATAI | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Mixed | — | $0 | EDGAR |
| 2025-06-02 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Sell (S) | −9,126 | -$18.3K | EDGAR |
| 2025-02-27 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-08-06 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |